Recessive Model |
APOL1 |
0.80 |
(0.35,1.86) |
0.61 |
Recipient gender (female) |
0.79 |
(0.43,1.47) |
0.49 |
Recipient ethnicity (African American) |
0.59 |
(0.25,1.41) |
0.24 |
Recipient age at transplant |
0.98 |
(0.96,0.99) |
0.01 |
Donor age |
1.01 |
(0.98,1.04) |
0.35 |
Expanded-criteria donor (No) |
0.71 |
(0.26,1.90) |
0.49 |
Previous liver transplant |
1.84 |
(0.73,4.65) |
0.20 |
Recipient previous hepatic malignancy |
1.35 |
(0.15,11.87) |
0.79 |
Recipient HCV Status (Ref = N) |
|
|
0.38 |
Not Detected |
2.33 |
(0.83,6.49) |
0.11 |
Positive |
1.32 |
(0.68,2.56) |
0.41 |
Unknown |
1.89 |
(0.31,11.64) |
0.49 |
Donor source (Ref = Wake Forest) |
|
|
0.45 |
Emory University |
0.84 |
(0.42,1.65) |
0.61 |
DeKAF Genomics |
0.56 |
(0.25,1.27) |
0.17 |
University of Alabama at Birmingham |
0.53 |
(0.18,1.57) |
0.25 |
Additive Model |
APOL1 |
0.91 |
(0.61,1.37) |
0.65 |
Recipient gender (female) |
0.79 |
(0.43,1.48) |
0.47 |
Recipient ethnicity (African American) |
0.59 |
(0.25,1.41) |
0.24 |
Recipient age at transplant |
0.98 |
(0.96,0.99) |
0.01 |
Donor age |
1.01 |
(0.98,1.04) |
0.36 |
Expanded-criteria donor (No) |
0.69 |
(0.26,1.86) |
0.47 |
Previous liver transplant |
1.81 |
(0.72,4.58) |
0.21 |
Recipient previous hepatic malignancy |
1.35 |
(0.15,11.99) |
0.79 |
Recipient HCV Status (Ref = N) |
|
|
0.38 |
Not Detected |
2.33 |
(0.84,6.45) |
0.10 |
Positive |
1.33 |
(0.69,2.57) |
0.40 |
Unkown |
1.88 |
(0.3,11.80) |
0.50 |
Donor source (Ref = Wake Forest) |
|
|
0.46 |
Emory University |
0.84 |
(0.43,1.66) |
0.62 |
DeKAF Genomics |
0.57 |
(0.25,1.27) |
0.17 |
University of Alabama at Birmingham |
0.54 |
(0.18,1.58) |
0.26 |